Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2017 Sep 25;55(10):3135–3137. doi: 10.1128/JCM.00920-17

Cross-Reacting Ustilago maydis Causing False-Positive Cryptococcal Antigen Test Results

Matthew P Cheng a,, Tien T Nguyen a, Leighanne O Parkes a, Philippe J Dufresne b, Donald C Sheppard a,c
Editor: David W Warnock
PMCID: PMC5625399  PMID: 28747366

LETTER

Cryptococcus neoformans is a yeast within the division Basidiomycota that may cause pulmonary and central nervous system (CNS) disease. Latex agglutination (LA) and lateral flow assay (LFA) for detection of cryptococcal polysaccharide antigen are sensitive and specific tests for diagnosis of invasive disease (1, 2); however, cross-reactivity has been described with Trichosporon asahii (3). Our objective was to determine if there is cross-reactivity with other Basidiomycete yeasts, including rare agents of human disease such as Rhodotorula, Sporobolomyces, and Ustilago spp. (48).

Clinical isolates of Trichosporon, Rhodotorula, Sporobolomyces, and Ustilago spp. were retrieved from the Quebec provincial reference laboratory (LSPQ). Sporobolomyces, Trichosporon asahii, Rhodotorula glutinis, R. minuta, and R. mucilaginosa isolates were taxonomically confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) (Vitek MS; bioMérieux, Inc., Saint-Laurent, Quebec, Canada). Ustilago spp. and Rhodotorula slooffiae were confirmed by sequencing their ribosomal DNA D1-D2 and internal transcribed spacer (ITS) regions. Cryptococcus neoformans (LSPQ-16-A479650) and Candida albicans (ATCC 60433) strains were used as positive and negative controls, respectively. Growth in Sabouraud dextrose broth was confirmed by measuring the increase in optical density after 24 h (DensiCHEK Plus; bioMérieux, Inc.). Turbidity was adjusted to a 0.5 McFarland (MF) standard equivalent, and organism count/ml was determined by a hemocytometer. This turbidity corresponded to an average of 3.2 organisms/ml (standard deviation, 0.9 organisms/ml), which is similar to the organism burden reported to occur in the cerebrospinal fluid of patients with cryptococcal meningitis (9). Serial 2-fold dilutions were performed to determine the cutoff for positivity.

LA testing was performed using the CALAS cryptococcal antigen latex agglutination kit (Meridian Bioscience, Inc., Cincinnati, OH, USA). Flocculation was graded on a scale from 0 to 4+, with 2 or higher representing a positive result. LFA was performed using the IMMY cryptococcal lateral flow assay (Immuno-Mycologics, Inc., Norman, OK, USA). Both assays were performed per the manufacturers' instructions, and assessment was made in a blind fashion. In total, 23 samples were tested, including 9 isolates of Rhodotorula spp., 5 isolates of Sporobolomyces salmonicolor, 3 isolates of Trichosporon asahii, and 3 isolates of Ustilago maydis (Table 1). Only C. neoformans, Trichosporon, and Ustilago isolates were unequivocally positive by both assays. One Rhodotorula mucilaginosa isolate and one Sporobolomyces salmonicolor isolate had discordant results; these isolates were weakly positive by the LA assay at titers of 1:1 and 1:4, respectively, but were negative by the LFA. All other isolates had concordant results between assays at a 0.5 MF standard equivalent, although some isolates had different cutoffs for positivity (Table 1).

TABLE 1.

Interassay agreement

Sample group No. of isolates Cryptococcal antigen latex test
Cryptococcal LFA
Result Titer Result Titer
Sabouraud dextrose broth (negative control) NAa 1+ NA NA
C. albicans ATCC 60433 (negative control) 1 1+ NA NA
C. neoformans (positive control) 1 4+ 1:1,024 + 1:256
Rhodotorula glutinis 1 1+ NA NA
Rhodotorula minuta 2 1+ NA NA
Rhodotorula mucilaginosab 5 1+ NA NA
Rhodotorula slooffiae 1 1+ NA NA
Sporobolomyces salmonicolorc 5 1+ NA NA
Trichosporon asahii 3 4+ 1:32 + 1:32
Ustilago maydis 3 4+ 1:32 + 1:16
a

NA, not applicable.

b

A single Rhodotorula mucilaginosa isolate was weakly positive by the cryptococcal antigen latex test at a titer of 1:1.

c

A single Sporobolomyces salmonicolor isolate was weakly positive by the cryptococcal antigen latex test at a titer of 1:4.

Our findings demonstrate that unlike Rhodotorula and Sporobolomyces spp., Trichosporon asahii and Ustilago maydis yield positive results in cryptococcal antigen assays at clinically relevant concentrations, with excellent interassay agreement. The plant pathogen Ustilago (the agent of corn smut) and the closely related genus Pseudozyma are ubiquitous in the environment and are commonly regarded as laboratory contaminants. However, these organisms can be transmitted by the airborne route and have occasionally caused fungemia and central venous catheter infections in humans (5, 7, 1016).

In conclusion, our results validate the cross-reactivity of Trichosporon asahii as previously reported and help delineate the limitations in specificity of cryptococcal antigen testing for the detection of other basidiomycetous yeasts. Although this study is limited to in vitro observations, our results suggest that these tests should not be used as an adjunct to diagnose invasive infections caused by Rhodotorula or Sporobolomyces species but may be considered for Trichosporon asahii and Ustilago maydis. The fact that not all Basidiomycetes tested produced a cross-reaction in the two assays suggests there is no conserved cross-reacting antigen produced by all members of the division Basidiomycota.

ACKNOWLEDGMENTS

M.P.C., T.T.N., and L.O.P. performed literature searches, devised the experiments, and drafted the manuscript. P.J.D. and D.C.S. were responsible for the overall content.

We declare that we have no conflicts of interest.

This project was done as part of routine work. D.C.S. was supported by a research chair from the Fonds de Recherche Quebec Santé.

REFERENCES

  • 1.Hansen J, Slechta ES, Gates-Hollingsworth MA, Neary B, Barker AP, Bauman S, Kozel TR, Hanson KE. 2013. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol 20:52–55. doi: 10.1128/CVI.00536-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kauffman CA, Bergman AG, Severance PJ, McClatchey KD. 1981. Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol 75:106–109. doi: 10.1093/ajcp/75.1.106. [DOI] [PubMed] [Google Scholar]
  • 3.McManus EJ, Jones JM. 1985. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 21:681–685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group, European Confederation of Medical Mycology. 2014. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 20(Suppl 3):S76–S98. doi: 10.1111/1469-0691.12360. [DOI] [PubMed] [Google Scholar]
  • 5.McGhie TA, Huber TW, Kassis CE, Jinadatha C. 2013. Ustilago species as a cause of central line-related blood stream infection. Am J Med Sci 345:254–255. doi: 10.1097/MAJ.0b013e31826f56ed. [DOI] [PubMed] [Google Scholar]
  • 6.Moore M, Russell WO, Sachs E. 1946. Chronic Leptomeningitis and ependymitis caused by Ustilago, probably U. zeae (corn smut). Am J Pathol 22:761–777. [PubMed] [Google Scholar]
  • 7.Patel R, Roberts GD, Kelly DG, Walker RC. 1995. Central venous catheter infection due to Ustilago species. Clin Infect Dis 21:1043–1044. doi: 10.1093/clinids/21.4.1043. [DOI] [PubMed] [Google Scholar]
  • 8.Stewart E, Waldman S, Sutton DA, Sanders C, Lindner J, Fan H, Wiederhold NP, Thompson GR III. 2016. Ustilago echinata: infection in a mixed martial artist following an open fracture. Mycopathologia 181:311–314. doi: 10.1007/s11046-015-9967-1. [DOI] [PubMed] [Google Scholar]
  • 9.Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, Longley N, Muzoora C, Phulusa J, Taseera K, Kanyembe C, Wilson D, Hosseinipour MC, Brouwer AE, Limmathurotsakul D, White N, van der Horst C, Wood R, Meintjes G, Bradley J, Jaffar S, Harrison T. 2014. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis 58:736–745. doi: 10.1093/cid/cit794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Herb A, Sabou M, Delhorme JB, Pessaux P, Mutter D, Candolfi E, Letscher-Bru V. 2015. Pseudozyma aphidis fungemia after abdominal surgery: first adult case. Med Mycol Case Rep 8:37–39. doi: 10.1016/j.mmcr.2015.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Joo H, Choi YG, Cho SY, Choi JK, Lee DG, Kim HJ, Jo I, Park YJ, Lee KY. 2016. Pseudozyma aphidis fungaemia with invasive fungal pneumonia in a patient with acute myeloid leukaemia: case report and literature review. Mycoses 59:56–61. doi: 10.1111/myc.12435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lin SS, Pranikoff T, Smith SF, Brandt ME, Gilbert K, Palavecino EL, Shetty AK. 2008. Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome. J Med Microbiol 57:516–518. doi: 10.1099/jmm.0.47563-0. [DOI] [PubMed] [Google Scholar]
  • 13.Orecchini LA, Olmos E, Taverna CG, Murisengo OA, Szuzs W, Vivot W, Cordoba S, Bosco-Borgeat ME, Montanaro PC. 2015. First case of fungemia due to Pseudozyma aphidis in a pediatric patient with osteosarcoma in Latin America. J Clin Microbiol 53:3691–3694. doi: 10.1128/JCM.01095-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pande A, Non LR, Romee R, Santos CA. 6 March 2017. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transpl Infect Dis doi: 10.1111/tid.12664. [DOI] [PubMed] [Google Scholar]
  • 15.Prakash A, Wankhede S, Singh PK, Agarwal K, Kathuria S, Sengupta S, Barman P, Meis JF, Chowdhary A. 2014. First neonatal case of fungaemia due to Pseudozyma aphidis and a global literature review. Mycoses 57:64–68. doi: 10.1111/myc.12098. [DOI] [PubMed] [Google Scholar]
  • 16.Siddiqui W, Ahmed Y, Albrecht H, Weissman S. 2014. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review. BMJ Case Rep 2014:pii=bcr2014206369. doi: 10.1136/bcr-2014-206369. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES